ICOSAVAX, INC. Active Patents
2 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-09-06: Application 18461862; Invention PROTEIN-BASED NANOPARTICLE VACCINE FOR METAPNEUMOVIRUS; Applicant Icosavax, Inc.; Status Patented Case.
- 2023-03-24: Application 18126140; Invention PROTEIN-BASED NANOPARTICLE VACCINE FOR METAPNEUMOVIRUS; Applicant Icosavax, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-06 | 18461862 | PROTEIN-BASED NANOPARTICLE VACCINE FOR METAPNEUMOVIRUS | Icosavax, Inc. | Patented Case | 2025-07-01 | 12343391 | US20240216499A1 | Andrew Lawrence Feldhaus Douglas Andrew Holtzman Clancey Buchanan Wolf | United States United States United States | CHESTNUT, BARRY A |
| 2023-03-24 | 18126140 | PROTEIN-BASED NANOPARTICLE VACCINE FOR METAPNEUMOVIRUS | Icosavax, Inc. | Patented Case | 2023-11-07 | 11806394 | US20230241199A1 | Andrew Lawrence Feldhaus Douglas Andrew Holtzman Clancey Buchanan Wolf | United States United States United States | CHESTNUT, BARRY A |